Last reviewed · How we verify
NCT03933722
Caretaker vs. Blood Pressure Monitoring With Invasive Arterial Pressure Monitoring in Patients With Septic Shock
trial testing Caretaker in Blood Pressure in 40 participants. Status unknown.
5 February 2024
Quick facts
| Lead sponsor | The Cooper Health System |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 4 February 2019 |
| Primary completion | 5 February 2024 |
| Estimated completion | 5 February 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Caretaker
Conditions studied
- Blood Pressure — all drugs for Blood Pressure →
Sponsor
The Cooper Health System — full company profile →
Who can join
18 and older, any sex, with Blood Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Caretaker vs. Blood Pressure Monitoring With Invasive Arterial Pressure Monitoring in Patients With Septic Shock
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03933722
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Caretaker
Trials testing the same drug.
- NCT04665011 — Validation of Indicor Photoplethysmography (PPG) Valsalva Pulse Response vs Non-invasive Blood Pressure · completed
- NCT03918486 — Caretaker vs. Routine Blood Pressure Sphygmomanometer · completed
Other recruiting trials for Blood Pressure
Currently open trials in the same condition.
- NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
- NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
- NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
- NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
- NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting
Other The Cooper Health System trials
Trials by the same sponsor.
- NCT07296120 — RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients · Phase 4 · not yet recruiting
- NCT07042048 — Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization · NA · not yet recruiting
- NCT06462781 — Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1 · Phase 1 · completed
- NCT05974423 — Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair · Phase 4 · unknown
- NCT06398366 — Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03933722 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Cooper Health System
- Last refreshed: 7 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03933722.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing